Litcius/Paper detail

The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP

Jonathan D. Douros, Jonathan N. Flak, Patrick J. Knerr

2025Frontiers in Endocrinology13 citationsDOIOpen Access PDF

Topics & Concepts

Adverse effectGlucagon-like peptide-1MedicineInternal medicineEndocrinologyType 2 diabetesDiabetes mellitusDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiet and metabolism studies
The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP | Litcius